Utpal Koppikar - 07 Feb 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Chief Financial Officer
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact for Utpal Koppikar
Issuer symbol
ATRA
Transactions as of
07 Feb 2023
Net transactions value
-$13,568
Form type
4
Filing time
09 Feb 2023, 16:00:12 UTC
Previous filing
18 Nov 2022
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $13,568 -2,485 -1.3% $5.46 188,849 07 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.